Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Acadia Healthcare Company (ACHC) over the last 15 years, with Q3 2025 value amounting to $6.0 million.

  • Acadia Healthcare Company's Share-based Compensation fell 3651.58% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year decrease of 242.97%. This contributed to the annual value of $37.1 million for FY2024, which is 1490.09% up from last year.
  • Per Acadia Healthcare Company's latest filing, its Share-based Compensation stood at $6.0 million for Q3 2025, which was down 3651.58% from $10.5 million recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Share-based Compensation registered a high of $12.5 million during Q4 2021, and its lowest value of $6.0 million during Q3 2025.
  • Moreover, its 5-year median value for Share-based Compensation was $8.7 million (2024), whereas its average is $8.5 million.
  • As far as peak fluctuations go, Acadia Healthcare Company's Share-based Compensation skyrocketed by 10196.65% in 2021, and later crashed by 3703.11% in 2022.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Share-based Compensation stood at $12.5 million in 2021, then tumbled by 37.03% to $7.9 million in 2022, then grew by 16.1% to $9.2 million in 2023, then rose by 10.25% to $10.1 million in 2024, then tumbled by 40.28% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $10.5 million for Q2 2025, and $8.7 million during Q1 2025.